Showing 1,441 - 1,460 results of 101,478 for search '(( 5 non decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.69s Refine Results
  1. 1441
  2. 1442
  3. 1443
  4. 1444

    Image_2_SIRT1 haplo-insufficiency results in reduced cortical bone thickness, increased porosity and decreased estrogen receptor alpha in bone in adult 129/Sv female mice.tif by Hanna Artsi (777390)

    Published 2022
    “…</p>Methods<p>To investigate the mechanisms of gender differences in SIRT1 skeletal effect, we investigated femoral and vertebral cortical and cancellous bone in global Sirt1 haplo-insufficient 129/Sv mice aged 2,7,12 months lacking Sirt1 exons 5,6,7 (Sirt1<sup>+/Δ</sup>) and their wild type (WT) counterparts.…”
  5. 1445

    Image_1_SIRT1 haplo-insufficiency results in reduced cortical bone thickness, increased porosity and decreased estrogen receptor alpha in bone in adult 129/Sv female mice.tif by Hanna Artsi (777390)

    Published 2022
    “…</p>Methods<p>To investigate the mechanisms of gender differences in SIRT1 skeletal effect, we investigated femoral and vertebral cortical and cancellous bone in global Sirt1 haplo-insufficient 129/Sv mice aged 2,7,12 months lacking Sirt1 exons 5,6,7 (Sirt1<sup>+/Δ</sup>) and their wild type (WT) counterparts.…”
  6. 1446

    Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients’ skin fibroblasts by Nicola Chiarelli (756982)

    Published 2019
    “…<div><p>Classical Ehlers-Danlos syndrome (cEDS) is a dominant inherited connective tissue disorder mainly caused by mutations in the <i>COL5A1</i> and <i>COL5A2</i> genes encoding type V collagen (COLLV), which is a fibrillar COLL widely distributed in a variety of connective tissues. cEDS patients suffer from skin hyperextensibility, abnormal wound healing/atrophic scars, and joint hypermobility. …”
  7. 1447
  8. 1448
  9. 1449

    Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A by Rodrigo Velázquez-Moctezuma (3776023)

    Published 2017
    “…Culturing J6/JFH1<sub>ΔHVR1</sub> (genotype 2a), for which fitness was decreased by L665W, with AR5A generated AR5A-resistant viruses with the substitutions I345V, L665S, and S680T, which we introduced into J6/JFH1 and J6/JFH1<sub>ΔHVR1</sub>. …”
  10. 1450
  11. 1451
  12. 1452

    Related to Fig 5A. by Rani Moran (3315630)

    Published 2021
    “…<p>The findings for vegetables were similar to the findings for animal reported in the main text: we found a positive effect for the high-vegetable reward (b = 0.24, t(1736) = 4.33, p = 2e-5) and non-significant effects for the low (b = -0.11, t(1736) = -1.42, p = .156) and unrelated (b = 0.08, t(1736) = 1.88, p = .06) vegetable-reward. …”
  13. 1453

    Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality by Johannes Raffler (793347)

    Published 2015
    “…In contrast, for the <i>SLC5A11</i> locus, we found increased levels of <i>myo</i>-inositol in urine whereas mGWAS in blood reported decreased levels for the same genetic variant. …”
  14. 1454
  15. 1455

    Synergistic Impaired Effect between Smoking and Manganese Dust Exposure on Pulmonary Ventilation Function in Guangxi Manganese-Exposed Workers Healthy Cohort (GXMEWHC) by Fenfen Wang (690916)

    Published 2015
    “…In particular, among the exposed subjects smokers had a statistically significant decrease in lung function compared with non-smokers and the reduction in FVC% predicted, MMEF and MMEF% predicted was 1.0%, 210 mL/s, and 4.9%, respectively (<i>p</i><0.05). …”
  16. 1456
  17. 1457

    Flowchart of patients. by Seydou Goro (17847203)

    Published 2024
    “…Using the number of competitors per distance method, our study showed that a “highly competitive” and “moderately competitive” markets decreased mortality by 31% [OR: 0.69 (0.59, 0.80); p<0.001] and by 12% respectively [OR: 0.88 (0.79, 0.99); p<0.03], compared to the “non-competitive” market. …”
  18. 1458

    Baseline characteristics of patients. by Seydou Goro (17847203)

    Published 2024
    “…Using the number of competitors per distance method, our study showed that a “highly competitive” and “moderately competitive” markets decreased mortality by 31% [OR: 0.69 (0.59, 0.80); p<0.001] and by 12% respectively [OR: 0.88 (0.79, 0.99); p<0.03], compared to the “non-competitive” market. …”
  19. 1459
  20. 1460